Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cyclobenzaprine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 214Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tonix Announces TNX-102 SL Presentations At PDDS 2024
    Tonix Announces TNX-102 SL Presentations At PDDS 2024

    23 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/23/2951242/28908/en/Tonix-Pharmaceuticals-Announces-Data-Presentations-on-TNX-102-SL-for-Fibromyalgia-at-the-11th-Global-Conference-on-Pharmaceutics-and-Novel-Drug-Delivery-Systems-PDDS-2024.html

    GLOBENEWSWIRE
    23 Sep 2024
    Share Share
    Tonix Pharmaceuticals Presented TNX-102 SL Data At MHSRS 2024
    Tonix Pharmaceuticals Presented TNX-102 SL Data At MHSRS 2024

    28 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/28/2936884/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-the-2024-Military-Health-System-Research-Symposium-MHSRS.html

    GLOBENEWSWIRE
    28 Aug 2024
    Share Share
    Novast labs`s Generics Cyclobenzaprine HCl Receives Approval in US
    Novast labs`s Generics Cyclobenzaprine HCl Receives Approval in US

    27 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214732

    FDA
    27 Aug 2024
    Share Share
    Tonix Reports Q2 2024 Results And Operational Highlights
    Tonix Reports Q2 2024 Results And Operational Highlights

    19 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/19/2931973/28908/en/Tonix-Pharmaceuticals-Reports-Second-Quarter-2024-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    19 Aug 2024
    Share Share
    Macleods Pharma's Generics Cyclobenzaprine HCl Receives Approval in US
    Macleods Pharma's Generics Cyclobenzaprine HCl Receives Approval in US

    22 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207314

    FDA
    22 Jul 2024
    Share Share
    Tonix Reports Positive Pre-NDA Meeting With FDA For Fibromyalgia Drug
    Tonix Reports Positive Pre-NDA Meeting With FDA For Fibromyalgia Drug

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909571/28908/en/Tonix-Pharmaceuticals-Reports-Final-Positive-Pre-NDA-Meeting-with-FDA-for-Tonmya-for-the-Management-of-Fibromyalgia.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share